Uncategorized

Cancer has long been the leading cause of death in Hong Kong. According to the Hong Kong Cancer Registry, cancer has consistently ranked among the top ten causes of death in the city for many years. Although surgery, chemotherapy, radiotherapy, targeted therapy, and immunotherapy have made significant progress, many patients still face substantial challenges: severe side effects, tumor recurrence and metastasis, and even drug resistance. These issues leave many patients feeling hopeless despite receiving standard treatments.

In Hong Kong, cancer has long been the leading cause of death. According to the Hong Kong Cancer Registry, approximately 30,000 new cases are diagnosed each year, and the number of deaths continues to rise. For patients, fighting cancer is not just about “eliminating tumors”; it is a long-term battle. On one hand, patients must endure the side effects of treatment; on the other, they strive to maintain daily life and quality of life.

Cancer patients facing treatment decisions often hope for options beyond surgery, chemotherapy, radiotherapy, and targeted therapies that could reduce recurrence risk, improve quality of life, and support immune function. Peptide therapy has emerged as an adjunctive approach receiving significant attention in recent international research and clinical studies. This article provides a systematic overview of peptide therapy from a cancer patient’s perspective, covering its mechanisms of action, scientific evidence, practical benefits, potential risks, and considerations for adoption in Hong Kong, aiming to offer clear and reliable information for patients and caregivers exploring treatment options.

Alpha-Lipoic Acid (ALA) is a sulfur-containing compound with both water-soluble and fat-soluble properties, allowing it to act in various cellular environments. As a key coenzyme in mitochondrial energy metabolism and a potent antioxidant, ALA has attracted attention in the cancer field. Many patients in Hong Kong, besides undergoing conventional cancer treatments (such as surgery, radiotherapy, chemotherapy, and immunotherapy), also seek nutritional supplementation and functional medicine interventions to alleviate side effects, enhance immunity, and improve quality of life. This article explores ALA’s mechanisms, research evidence, and applications from a patient-centered perspective.

In Hong Kong’s healthcare environment, more and more patients hear doctors suggest “albumin supplementation.” But what exactly is albumin, and why do some patients need intravenous infusion? Is it driven by medical necessity or routine practice? How can patients and their families make informed decisions when information is limited? This article explores the clinical role, risks, controversies, and patient autonomy regarding albumin infusion from a patient-centered perspective in Hong Kong.